<DOC>
	<DOCNO>NCT00015210</DOCNO>
	<brief_summary>The purpose study use Nefazodone treatment cocaine dependence depression comorbidity .</brief_summary>
	<brief_title>Nefazodone Treatment Cocaine Dependence Depression - 4</brief_title>
	<detailed_description>The objective study determine safety efficacy nefazodone ( Serzone ) depress cocaine dependent subject . This hypothesis-testing study explore whether cocaine usage reduce nefazodone treatment group compare placebo control group .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Nefazodone</mesh_term>
	<criteria>DSMIV diagnosis cocaine dependence , Depression score 12 history depression . Males nonpregnant , nonnursing female 2155 year age . Axis I diagnosis substance use disorder , major depression , anxiety dysthymic disorder . Physiological dependence alcohol . Significant medical neurological history . Abnormal UA , CBC Chem 23 ( LFT 's may 3 time normal ) . Enrollment opiatesubstitution treatment program within 45 day enrollment present study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Cocaine Use Disorders Dependence Depression</keyword>
</DOC>